Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances
Susan Pyne, David R. Adams, Nigel J. Pyne
Progress in Lipid Research (2016) Vol. 62, pp. 93-106
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

M2b macrophage polarization and its roles in diseases
Lexun Wang, Sheng-xi Zhang, Huijuan Wu, et al.
Journal of Leukocyte Biology (2018) Vol. 106, Iss. 2, pp. 345-358
Open Access | Times Cited: 684
Lipid metabolism in cancer progression and therapeutic strategies
Yan Fu, Tiantian Zou, Xiaotian Shen, et al.
MedComm (2020) Vol. 2, Iss. 1, pp. 27-59
Open Access | Times Cited: 215
Bile acids and their receptors in metabolic disorders
Stefano Fiorucci, Eleonora Distrutti, Adriana Carino, et al.
Progress in Lipid Research (2021) Vol. 82, pp. 101094-101094
Closed Access | Times Cited: 175
The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
Samar Sami Alkafaas, Mohamed I. Elsalahaty, Doha F. Ismail, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 26
The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer
Nitai C. Hait, Aparna Maiti
Mediators of Inflammation (2017) Vol. 2017, pp. 1-17
Open Access | Times Cited: 163
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors
Carolyn D. Britten, Elizabeth Garrett‐Mayer, Steven Chin, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 16, pp. 4642-4650
Open Access | Times Cited: 144
Sphingolipid biosynthesis in man and microbes
Peter J. Harrison, Teresa Dunn, Dominic J. Campopiano
Natural Product Reports (2018) Vol. 35, Iss. 9, pp. 921-954
Open Access | Times Cited: 140
Sphingosine-1-phosphate receptors and innate immunity
Arielle M. Bryan, Maurizio Del Poeta
Cellular Microbiology (2018) Vol. 20, Iss. 5, pp. e12836-e12836
Open Access | Times Cited: 139
Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease
Ronald T. Riley, Alfred H. Merrill
Journal of Lipid Research (2019) Vol. 60, Iss. 7, pp. 1183-1189
Open Access | Times Cited: 126
Role of bioactive sphingolipids in physiology and pathology
Ana Gómez-Larrauri, Natalia Presa, Asier Dominguez-Herrera, et al.
Essays in Biochemistry (2020) Vol. 64, Iss. 3, pp. 579-589
Closed Access | Times Cited: 111
Sphingosine 1-phosphate and cancer
Nigel J. Pyne, Ashref El Buri, David R. Adams, et al.
Advances in Biological Regulation (2017) Vol. 68, pp. 97-106
Open Access | Times Cited: 104
Sphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
Andreas Weigert, Catherine Olesch, Bernhard Brüne
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 102
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
Diana Hatoum, Nahal Haddadi, Yiguang Lin, et al.
Oncotarget (2017) Vol. 8, Iss. 22, pp. 36898-36929
Open Access | Times Cited: 91
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
Sara Grassi, Laura Mauri, Simona Prioni, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 91
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
Alessandro Cannavò, Daniela Liccardo, Klara Komici, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 90
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling
Jiaxin Li, Runze Li, Ao Sun, et al.
Pharmacological Research (2021) Vol. 171, pp. 105574-105574
Closed Access | Times Cited: 67
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
Alhaji H. Janneh, Besim Öğretmen
Cancers (2022) Vol. 14, Iss. 9, pp. 2183-2183
Open Access | Times Cited: 45
Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets
Miguel L. Rufail, Rosaria Bassi, Paola Giussani
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1056-1056
Open Access | Times Cited: 1
Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase
Joanna Motyl, Łukasz Przykaza, Paweł M. Boguszewski, et al.
Neuropharmacology (2018) Vol. 135, pp. 139-150
Closed Access | Times Cited: 82
Mechanisms of sphingosine 1-phosphate receptor signalling in cancer
Sathya Narayanan Patmanathan, Wei Wang, Lee Fah Yap, et al.
Cellular Signalling (2017) Vol. 34, pp. 66-75
Closed Access | Times Cited: 73
Orm/ORMDL proteins: Gate guardians and master regulators
Deanna Davis, Muthukumar Kannan, Binks W. Wattenberg
Advances in Biological Regulation (2018) Vol. 70, pp. 3-18
Open Access | Times Cited: 71
The role of sphingolipid signalling in diabetes-associated pathologies (Review)
Mah Lee Ng, Carol Wadham, Olga Sukocheva
International Journal of Molecular Medicine (2017) Vol. 39, Iss. 2, pp. 243-252
Open Access | Times Cited: 64
Glucocerebrosidase: Functions in and Beyond the Lysosome
Daphne E.C. Boer, Jeroen van Smeden, Joke A. Bouwstra, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 736-736
Open Access | Times Cited: 54
Kinase Inhibitors as Underexplored Antiviral Agents
Javier García‐Cárceles, Elena Caballero, Carmen Gil, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 935-954
Open Access | Times Cited: 54
Sphingolipids as Modulators of SARS-CoV-2 Infection
Kid Törnquist, Muhammad Yasir Asghar, Vignesh Srinivasan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top